Cost-Effectiveness of Noninvasive Colorectal Cancer Screening in Community Clinics
This study suggests that in a federally qualified health care setting, prioritizing the convenience of blood tests over less costly and more effective existing stool-based tests could result in higher costs and worse population-level outcomes. Novel screening modalities should be carefully evaluated for performance in community settings before widespread adoption.
Authors
- Anne L. Escaron (ORCID: https://orcid.org/0000-0003-0717-0750)
- Laura Matrajt (ORCID: https://orcid.org/0000-0003-4495-7245)
- Carolyn M. Rutter (ORCID: https://orcid.org/0000-0002-4396-8594)
- Gloria D. Coronado (ORCID: https://orcid.org/0000-0003-1130-6542)
- Pedro Nascimento de Lima (ORCID: https://orcid.org/0000-0001-9057-198X)
Institutions
- RAND Corporation (US)
- University of Arizona (US)
- Fred Hutch Cancer Center (US)
- University of Washington Applied Physics Laboratory (US)
- AltaMed (US)
- University of Arizona Cancer Center
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.54938
- Citations
- 17
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 17.77